Allergan Faces DOJ Subpoena Over Botox
Deepening Allergan Inc.'s troubles over Botox, the company disclosed Monday it has been slapped with a subpoena from the U.S. Department of Justice regarding alleged promotion of off-label uses for the...To view the full article, register now.
Already a subscriber? Click here to view full article